Dr. Robert W. Yeh, MD
Interventional Cardiology (Interventional Cardiology Physician)
185 Pilgrim Road, Beth Israel Deaconess Medical Center, Baker 4
Boston, MA 02215
- Medicare participating
At a glance
- Medical school
- Harvard Medical School (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 283
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: Harvard Medical School
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
MA license 224353 -
Cardiovascular Disease Physician
MA license 224353 -
Internal Medicine Physician
MA license 224353
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Beth Israel Deaconess Medical Center Boston, MA
- Beth Israel Deaconess Hospital Plymouth Plymouth, MA
Medical groups
- Harvard Medical Faculty Phys at Beth Israel Deaconess Med Ctr Inc (1,740 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 283
- Services billed
- 609
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 153 | 147 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 153 | 144 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 78 | 78 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 58 | 56 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 46 | 36 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 17 | 13 |
| Insertion of tube in right heart chambers for measurement | 16 | 16 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 12 | 12 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 9 companies reported 56 payments worth $56,866 in total to this clinician.
| Boston Scientific Corporation | $22,395 |
|---|---|
| Medtronic, Inc. | $13,257 |
| Shockwave Medical, Inc | $9,013 |
| Cathworks, Inc. | $6,302 |
| Edwards Lifesciences Corporation | $3,386 |
| Magenta Medical Inc | $2,275 |
| Abbott Laboratories | $143 |
| Abiomed | $55.57 |
| Consulting Fee | $46,263 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $7,500 |
| Travel and Lodging | $1,668 |
| Food and Beverage | $1,435 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Medtronic, Inc. Oct 7, 2025 | Consulting Fee SYMPLICITY G3 · Renal Denervation System | $11,050 |
| Cathworks, Inc. Apr 8, 2025 | Consulting Fee FFRANGIO · Cardiology | $6,000 |
| Boston Scientific Corporation Jan 30, 2025 | Consulting Fee General - Structural Heart · General - Structural Heart_IC | $5,000 |
| Edwards Lifesciences Corporation Jan 23, 2025 | Consulting Fee | $3,250 |
| Shockwave Medical, Inc Mar 13, 2025 | Consulting Fee Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Cardiology | $3,000 |
| Boston Scientific Corporation Jan 9, 2025 | Consulting Fee General - Stents · General - Stents_IC | $2,813 |
| Boston Scientific Corporation Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) General - Vascular Access · General - Vascular Access_IC | $2,500 |
| Boston Scientific Corporation Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) General - Vascular Access · General - Vascular Access_IC | $2,500 |
| Magenta Medical Inc Jun 12, 2025 | Consulting Fee | $2,275 |
| Boston Scientific Corporation Jan 30, 2025 | Consulting Fee General - Stents · General - Stents_IC | $1,875 |
All 34 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Shockwave Medical, Inc Dec 11, 2025 | Consulting Fee Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Cardiology | $1,125 |
| Shockwave Medical, Inc Dec 11, 2025 | Consulting Fee Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Cardiology | $375 |
| Shockwave Medical, Inc Oct 16, 2025 | Consulting Fee Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Cardiology | $375 |
| Shockwave Medical, Inc Oct 10, 2025 | Consulting Fee Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Cardiology | $750 |
| Medtronic, Inc. Oct 7, 2025 | Consulting Fee SYMPLICITY G3 · Renal Denervation System | $11,050 |
| Shockwave Medical, Inc Oct 2, 2025 | Consulting Fee Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Cardiology | $375 |
| Medtronic, Inc. Sep 19, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $868 |
| Medtronic, Inc. Sep 9, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $349 |
| Medtronic, Inc. Sep 9, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $51.04 |
| Medtronic, Inc. Sep 8, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $349 |
| Medtronic, Inc. Sep 8, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $51.04 |
| Magenta Medical Inc Jun 12, 2025 | Consulting Fee | $2,275 |
| Shockwave Medical, Inc May 16, 2025 | Consulting Fee Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Cardiology | $375 |
| Shockwave Medical, Inc May 1, 2025 | Consulting Fee Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Cardiology | $750 |
| Shockwave Medical, Inc Apr 17, 2025 | Consulting Fee Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Cardiology | $375 |
| Boston Scientific Corporation Apr 10, 2025 | Consulting Fee General - Balloons · General - Balloons_PI | $625 |
| Cathworks, Inc. Apr 8, 2025 | Consulting Fee FFRANGIO · Cardiology | $6,000 |
| Shockwave Medical, Inc Mar 20, 2025 | Consulting Fee Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Cardiology | $750 |
| Shockwave Medical, Inc Mar 20, 2025 | Consulting Fee Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Cardiology | $375 |
| Shockwave Medical, Inc Mar 13, 2025 | Consulting Fee Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Cardiology | $3,000 |
| Boston Scientific Corporation Jan 30, 2025 | Consulting Fee General - Structural Heart · General - Structural Heart_IC | $5,000 |
| Boston Scientific Corporation Jan 30, 2025 | Consulting Fee General - Stents · General - Stents_IC | $1,875 |
| Boston Scientific Corporation Jan 30, 2025 | Consulting Fee General - Structural Heart · General - Structural Heart_IC | $625 |
| Boston Scientific Corporation Jan 30, 2025 | Consulting Fee General - Balloons · General - Balloons_PI | $625 |
| Shockwave Medical, Inc Jan 28, 2025 | Consulting Fee Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Cardiology | $375 |
| Edwards Lifesciences Corporation Jan 23, 2025 | Consulting Fee | $3,250 |
| Boston Scientific Corporation Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) General - Vascular Access · General - Vascular Access_IC | $2,500 |
| Boston Scientific Corporation Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) General - Vascular Access · General - Vascular Access_IC | $2,500 |
| Boston Scientific Corporation Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) General - Vascular Access · General - Vascular Access_IC | $1,250 |
| Boston Scientific Corporation Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) General - Vascular Access · General - Vascular Access_IC | $1,250 |
| Boston Scientific Corporation Jan 9, 2025 | Consulting Fee General - Stents · General - Stents_IC | $2,813 |
| Boston Scientific Corporation Jan 9, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $1,875 |
| Boston Scientific Corporation Jan 9, 2025 | Consulting Fee General - Stents · General - Stents_IC | $625 |
| Boston Scientific Corporation Jan 9, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $625 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 7 industry-funded studies in 2025, from 5 companies. The companies reported $529,126 in research payments for these studies, mostly to the institutions running them.
- Post-market long-term outcomes of the Edwards PASCAL mitral device
Edwards Lifesciences Corporation - Investigator Sponsored Research: A 1856374
Medtronic, Inc. - ALL-RISE
Cathworks, Inc. - AGENT Transportability Study: Applicability of the AGENT-IDE Trial Results to Real World Treatment of Patients with In-Stent Restenosis
Boston Scientific Corporation - A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)
Boston Scientific Corporation · Active, not recruiting · NCT04647253 - BIDMC DUA 2025 YEH 241595
Siemens Medical Solutions USA, Inc. - VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS)
Boston Scientific Corporation · Completed · NCT06132568
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.